Biodesix, Inc. (BDSX) short interest & options flow
NASDAQBDSX reports Q1 2026 results on May 8 with the stock carrying a 25% monthly loss into the print — yet showing signs of near-term stabilisation. The price action tells a split story. Shares fell sharply through April to close at $11.27, but clawed back more than 11% over the past week and added 1.7% on Monday. That recovery narrows the gap to the analyst consensus price target of…
- Market cap
- $115M
- Next earnings
- 26 Feb 2027
Key data as of 10 Nov 2026

BDSX news and analysis
RSSNo long-form analysis yet for BDSX. Pulse alerts and the live data picture are available on ORTEX.
Open BDSX on ORTEX →Want the live picture for BDSX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BDSX — free to start on ORTEX.
Sign up for free →Open BDSX on ORTEX